Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | NPC1 | O15118 | 5/20 | 0.50 |
| ▸ | RAB9A | P51151 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | HTT | P42858 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | PPIA | P62937 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11008586 | 0.98 | IDO1 (0.62) | IDO1KDM4EGAAMAPTNPC1 | |
| SCHEMBL5173169 | 0.98 | IDO1 (0.61) | IDO1KDM4EGAAMAPTNPC1 | |
| SCHEMBL28306051 | 0.90 | IDO1 (0.50) | IDO1KDM4EGAAMAPTNPC1 | |
| SCHEMBL4495740 | 0.85 | KDM4E (0.73) | IDO1KDM4EGAAMAPTNPC1 | |
| SCHEMBL29449726 | 0.85 | KDM4E (0.73) | IDO1KDM4EGAAMAPTNPC1 | |
| SCHEMBL11523761 | 0.85 | KDM4E (0.73) | IDO1KDM4EGAAMAPTNPC1 | |
| SCHEMBL20336230 | 0.85 | KDM4E (0.73) | IDO1KDM4EGAAMAPTNPC1 | |
| SCHEMBL16961159 | 0.83 | IDO1 (0.54) | IDO1KDM4EGAAMAPTNPC1 | |
| SCHEMBL11521138 | 0.83 | KDM4E (0.69) | IDO1KDM4EGAAMAPTNPC1 | |
| SCHEMBL11034755 | 0.82 | IDO1 (0.81) | IDO1KDM4EGAAMAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2008514598-A | — | — | 2008-05-08 | — | — | JP | claimed |
| EP-1794106-A1 | SULFONATED PHENOLS WITH NITROPHENOLS AS POLYMERIZATION INHIBITORS | Chemtura Corporation (US) | 2007-06-13 | — | — | EP | claimed |
| WO-2006036274-A1 | SULFONATED PHENOLS WITH NITROPHENOLS AS POLYMERIZATION INHIBITORS | CHEMTURA CORPORATION (US) | 2006-04-06 | — | — | WO | claimed |
| US-8691813-B2 | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors | Janssen Pharmaceuticals, Inc. (US) | 2014-04-08 | — | — | US | disclosed |
| US-20120035167-A1 | INDOLE AND BENZOXAZINE DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | Janssen Pharmaceuticals, Inc. | 2012-02-09 | — | — | US | disclosed |
| WO-2010097815-A2 | A TWO COMPONENT RECYCLABLE HETEROGENEOUS CATALYST, PROCESS FOR PREPARATION THEREOF AND ITS USE FOR PREPARATION OF AMINES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-09-02 | — | — | WO | disclosed |
| CN-100357258-C | Production of keto acids | CIBA SC HOLDING AG (CH) | 2007-12-26 | — | — | CN | disclosed |
| CN-1301962-C | Production of keto acids | CIBA SC HOLDING AG (CH) | 2007-02-28 | — | — | CN | disclosed |
| CN-1575274-A | Production of keto acids | CIBA SC HOLDING AG (CH) | 2005-02-02 | — | — | CN | disclosed |
| US-20040242891-A1 | Production of keto acids | CAMPBELL JONATHAN (GB) | 2004-12-02 | — | — | US | disclosed |
| EP-1442009-A1 | PRODUCTION OF KETO ACIDS | Ciba SC Holding AG (CH) | 2004-08-04 | — | — | EP | disclosed |
| EP-0411817-B1 | Process for preparing N-alkyl-substituted aminophenols | SUMITOMO CHEMICAL CO (JP) | 1994-04-06 | — | — | EP | disclosed |
| US-5276193-A | Reductive alkylation, addition of carboxylic acid to prevent by-product formation | SUMITOMO CHEMICAL CO., LTD. (JP) | 1994-01-04 | — | — | US | disclosed |
| US-5202485-A | Catalytic reductive alkylation of aminophenol using aldehyde or ketone | SUMITOMO CHEMICAL CO., LTD. (JP) | 1993-04-13 | — | — | US | disclosed |
| EP-0411817-A2 | Process for preparing N-alkyl-substituted aminophenols | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-02-06 | — | — | EP | disclosed |
| EP-0181505-B1 | IMPROVED METHOD FOR PRODUCING CYCLOALKYL AMINOPHENOL DERIVATIVES | KANZAKI PAPER MANUFACTURING COMPANY LIMITED (JP) | 1990-03-28 | — | — | EP | disclosed |
| US-4713488-A | REACTING AMINOPHENOLS AND CYCLOALKANONES IN THE PRESENCE OF A REDUCING AGENT | KANZAKI PAPER MANUFACTURING CO., LTD. (JP) | 1987-12-15 | — | — | US | disclosed |
| US-4695630-A | Cycloacetals | BAYER AKTIENGESELLSCHAFT (DE) | 1987-09-22 | — | — | US | disclosed |
| EP-0191345-A2 | Cycloacetals, process for their preparation and their use in the preparation of azalactones | BAYER AG (DE) | 1986-08-20 | — | — | EP | disclosed |
| EP-0181505-A1 | Improved method for producing cycloalkyl aminophenol derivatives | KANZAKI PAPER MANUFACTURING COMPANY LIMITED (JP) | 1986-05-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035167-A1 | INDOLE AND BENZOXAZINE DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | GRM2, GRM5, GRIA2 | IDO1 118/4885KDM4E 1942/4885GAA 3935/4885 |
| US-20040242891-A1 | Production of keto acids | PKLR, KHK, ME1 | IDO1 960/4885KDM4E 495/4885GAA 4000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.